Sunitinib for advanced renal cell cancer
Chris CoppinBC Cancer Agency and University of British Columbia, Vancouver, CanadaAbstract: Renal cell cancer has been refractory to drug therapy in the large majority of patients. Targeted agents including sunitinib have been intensively evaluated in renal cell cancer over the past 5 years. Sunitin...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-03-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/sunitinib-for-advanced-renal-cell-cancer-a58 |